| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 13 |
| 1 | ASPIRIN 325 MG | 13 |
| 2 | ASPIRIN 81 MG | 13 |
| 3 | PANTOPRAZOLE | 12 |
| 4 | APIXABAN | 11 |
| 5 | OMEPRAZOLE MAGNESIUM | 10 |
| 6 | CLOPIDOGREL | 9 |
| 7 | OMEPRAZOLE | 9 |
| 8 | LEVOTHYROXINE SODIUM | 8 |
| 9 | PREDNISONE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MATICO, SARSAPARILLA (SMILAX REGELII), THUJA OCCIDENTALIS, UNCARIA TOMENTOSA, PHYLLANTHUS NIRURI, POLYGONUM CUSPIDATUM | 1 | 0.0139 |
| 1 | LITHIUM CARBONICUM | 1 | 0.0106 |
| 2 | HALOBETASOL PROPIONATE AND TAZAROTENE | 1 | 0.0051 |
| 3 | NEOSTIGMINE METHYLSULFATE | 1 | 0.0023 |
| 4 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| 5 | FENOFIBRIC ACID | 1 | 0.0013 |
| 6 | LAZERTINIB | 1 | 0.0012 |
| 7 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 3 | 0.0008 |
| 8 | SUGAMMADEX SODIUM | 1 | 0.0008 |
| 9 | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 1 | Corticosteroid [EPC] | 18 |
| 2 | Factor Xa Inhibitor [EPC] | 15 |
| 3 | Atypical Antipsychotic [EPC] | 14 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 13 |
| 5 | Benzodiazepine [EPC] | 12 |
| 6 | Proton Pump Inhibitor [EPC] | 12 |
| 7 | Loop Diuretic [EPC] | 10 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 8 |
| 9 | Integrin Receptor Antagonist [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 4 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |
| 5 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 6 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 8 | PCSK9 Inhibitor [EPC] | 6 | 0.0002 |
| 9 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |